VEGFA and cancer: A deeper understanding of the molecular pathways has resulted in the development of more targeted and selective cancer therapies (such as human epidermal growth factor receptor (HER) 2 inhibitors and VEGF signaling pathway inhibitors), multitargeted tyrosine kinase inhibitors, immunomodulatory drugs, proteasome inhibitors, and ICIs [122].